Perfil
Dr. Marc d'Abbadie is an Investment Director at SPARK Impact Ltd. He is on the Board of Directors at Dadu Investments Ltd., Nwf4b Directors Ltd., Spark Nw Carry Partner LLP and Videregen Ltd.
Dr. d'Abbadie was previously employed as a Non-Executive Director by Evgen Pharma Plc, a Non-Executive Director by Evgen Ltd., a Non-Executive Director by Absynth Biologics Ltd., a Non-Executive Director by EnXray Ltd., a Consultant by McKinsey & Co., Inc., and a Non-Executive Director by Zilico Ltd.
He received his graduate degree from Trinity College, Cambridge and a doctorate degree from the University of Cambridge.
Cargos activos de Marc d'Abbadie
| Empresas | Cargo | Inicio |
|---|---|---|
SPARK Impact Ltd.
SPARK Impact Ltd. Investment ManagersFinance SPARK Impact invests in companies located in the United Kingdom. The firm targets companies operating in the fields of pharmaceuticals, biotechnology, diagnostics, clinical research, analytical services & sciences, healthcare technologies and medical devices. It provides financing for early and growth stage capital requirements. | Inversor de Capital Privado | - |
Videregen Ltd.
Videregen Ltd. BiotechnologyHealth Technology Operates a regenerative medicine company created to address the chronic shortage of organs for transplantation | Director/Miembro de la Junta | - |
Spark Nw Carry Partner LLP | Director/Miembro de la Junta | - |
Nwf4b Directors Ltd. | Director/Miembro de la Junta | - |
Dadu Investments Ltd. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Marc d'Abbadie.
| Empresas | Cargo | Fin |
|---|---|---|
| THERACRYF PLC | Director/Miembro de la Junta | 08/11/2018 |
EnXray Ltd.
EnXray Ltd. Information Technology ServicesTechnology Services Develops sterilization technology solutions for medical device manufacturing companies | Director/Miembro de la Junta | - |
Absynth Biologics Ltd.
Absynth Biologics Ltd. BiotechnologyHealth Technology Develops and manufactures immunological prophylaxis, novel vaccines and therapies | Director/Miembro de la Junta | - |
Zilico Ltd.
Zilico Ltd. BiotechnologyHealth Technology Develops a medical device to detect cervical cancer and pre-cancerous cells in the cervix | Director/Miembro de la Junta | - |
| ░░░░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formación de Marc d'Abbadie.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 13 |
|---|---|
Evgen Pharma Plc
Evgen Pharma Plc Medical/Nursing ServicesHealth Services Engages in the development of pharmaceutical products and focus on cancer & neurological disease | Health Services |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trinity College, Cambridge
Trinity College, Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Absynth Biologics Ltd.
Absynth Biologics Ltd. BiotechnologyHealth Technology Develops and manufactures immunological prophylaxis, novel vaccines and therapies | Health Technology |
Zilico Ltd.
Zilico Ltd. BiotechnologyHealth Technology Develops a medical device to detect cervical cancer and pre-cancerous cells in the cervix | Health Technology |
Evgen Ltd.
Evgen Ltd. Medical/Nursing ServicesHealth Services Develops novel glucosinolate based products for the prevention and treatment of human disease | Health Services |
SPARK Impact Ltd.
SPARK Impact Ltd. Investment ManagersFinance SPARK Impact invests in companies located in the United Kingdom. The firm targets companies operating in the fields of pharmaceuticals, biotechnology, diagnostics, clinical research, analytical services & sciences, healthcare technologies and medical devices. It provides financing for early and growth stage capital requirements. | Finance |
Videregen Ltd.
Videregen Ltd. BiotechnologyHealth Technology Operates a regenerative medicine company created to address the chronic shortage of organs for transplantation | Health Technology |
Spark Nw Carry Partner LLP | |
Nwf4b Directors Ltd. | |
Dadu Investments Ltd. | |
EnXray Ltd.
EnXray Ltd. Information Technology ServicesTechnology Services Develops sterilization technology solutions for medical device manufacturing companies | Technology Services |
- Bolsa de valores
- Insiders
- Marc d'Abbadie
















